APPRAISE: Assessment of Pain and Posterior Synechiae Reduction With Atropine, an Investigation of Post-Surgical Eyes
Recruiting
Phase 4
Interventional Study
Eye Disorders
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 62 (estimated)
- Sponsor
- University of California, San Francisco · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study will evaluate whether atropine eyedrops are beneficial when used after certain eye surgeries.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* patient undergoing vitrectomy surgery
* able to give informed consent
Exclusion Criteria:
* post-operative eyedrop regimens that include topical non steroidal anti-inflammatory medications
* subjects with altered post-operative eyedrop schedule for enhanced inflammation cont…
Contacts